Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane Domain 1 (TMD1) of the CFTR protein is a critical structural and functional component of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), an ATP-binding cassette (ABC) transporter-class ion channel. TMD1, together with TMD2, forms the core transmembrane pore that allows selective passage of anions such as chloride (Cl-) and bicarbonate (HCO3-). Mutations affecting residues within or near TMD1 can disrupt proper folding, trafficking to the plasma membrane, or function of CFTR—leading to cystic fibrosis phenotypes depending on mutation severity.
CFTR modulators (e.g., correctors, potentiators) affect the folding, trafficking, or gating of the CFTR protein, including its transmembrane domains.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane Domain 1 of CFTR (TMD1).